OncLive® On Air

Non-Small Cell Lung Cancer

Breast Cancer

Immunotherapy

Multiple Myeloma

Small Cell Lung Cancer

Clinical Trials

Bladder Cancer

Chronic Lymphocytic Leukemia

Oncology

Antibody Drug Conjugates

Prostate Cancer

Chronic Myeloid Leukemia

Triple Negative Breast Cancer

Pembrolizumab

Biomarker Testing

Hr-Positive Her2-Negative Metastatic Breast Cancer

Chemotherapy

BTK Inhibitors

Circulating Tumor DNA

KRAS

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

33 ratings

Publishes	Daily	Episodes	500	Founded	8 years ago
Number of Listeners		Categories	Health & FitnessScience

Listen to this Podcast

Guests Reviews Charts Talking Points

Latest Episodes

S18 Ep33: Current Approaches and Future Directions for Early-Stage TNBC

Highlights from the PER® CME activity "Current Approaches and Future Directions for Early-Stage TNBC" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.

In this podcast... more

4 Sep 2026 • 28 min • Most popular

S18 Ep32: Non–Small Cell Lung Cancer 2026 UPDATE

Two Onc Docs, hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armst... more

31 Aug 2026 • 13 min • Popular

S18 Ep31: FDA Approval Insights: Integrating RP1 Plus Nivolumab Into Post–PD-1 Melanoma Practice: With Michael K. Wong, MD, PhD, FRPC

In today's episode, we spoke with Michael K. Wong, MD, PhD, FRPC. Dr Wong is a physician at Roswell Park Comprehensive Cancer Center in Buffalo, New York.

In our exclusive interview, Dr Wong discussed the significance of the FDA’s accelerated approv... more

28 Aug 2026 • 22 min

S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD

Eric D. Whitman, MD, and Francis Paul Worden, MD, discuss the integration of immunotherapy into the cutaneous squamous cell carcinoma (CSCC) treatment paradigm and key considerations for navigating treatment selection for this patient population. The... more

28 Aug 2026 • 27 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc DocsSam and Karine

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

JAMA Clinical ReviewsJAMA Network

Research To Practice | Oncology VideosDr Neil Love

Recent Guests

Michael K. Wong

MD, PhD, FRPC; Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center

Episode: S18 Ep31: FDA Approval Insights: Integrating RP1 Plus Nivolumab Into Post–PD-1 Melanoma Practice: With Michael K. Wong, MD, PhD, FRPC

Eric Whitman, MD

Oncologist specializing in cutaneous squamous cell carcinoma and other advanced skin cancers

Atlantic Health, Morristown, New Jersey

Episode: S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD

Sagar Lonial

MD, FACP, FASCO; invited expert discussing FDA approval and trial data

Emory University/Winship Cancer Institute (as context from discussion)

Episode: S18 Ep30: FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma: With Sagar Lonial, MD, FACP, FASCO

Jennifer B. Valerin

MD, PhD, pancreatic cancer specialist

University affiliation not explicitly stated in transcript

Episode: S18 Ep28: Pancreatic Cancer Treatment Advances Call for a Renewed Focus on the Role of Liposomal Irinotecan: With Jennifer B. Valerin, MD, PhD

Adam M. Brufsky

MD, PhD, physician-scientist

University of Pittsburgh/UPMC

Episode: S18 Ep26: FDA Approval Insights: Gedatolisib Plus Fulvestrant ± Palbociclib for HR+, HER2-Negative, PIK3CA Wild-Type Advanced Breast Cancer: With Adam M. Brufsky, MD, PhD

Jonathan Trent

MD, PhD, oncologist

Episode: S18 Ep25: Greater Flexibility and Improved QOL Represent Key Potential Benefits With Liquid TKI Formulations: With Jonathan Trent, MD, PhD

Dr. Stephen Liu

Division Chief of Hematology Oncology, MedStar Georgetown University

MedStar Georgetown University

Episode: S18 Ep24: Precision Oncology, Bispecific Antibodies, and Next-Generation Targeted Therapies Are Reshaping NSCLC Care: With Chandler Park, MD; Stephen V. Liu, MD

Douglas W. Sborov

MD, MS; oncologist

Episode: S18 Ep22: FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS

Solange Peters

MD, PhD, full professor and chair of medical oncology and thoracic malignancies at the University Hospital of Lausanne, Switzerland

University Hospital of Lausanne

Episode: S18 Ep21: Positioning PD-L1/VEGF Bispecifics in First-Line Non–Small Cell Lung Cancer: With Solange Peters, MD, PhD

Reviews

4.5 out of 5 stars from 33 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United Statesa year ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States7 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners value data-driven discussion and expert guest diversity.

Great CME content for clinicians and researchers.

High-quality oncology insights and practical takeaways.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts

#239

Sweden/Health & Fitness

Talking Points

Recent interactions between the hosts and their guests.

S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD

Q: What are the alternatives to IO therapy for ineligible patients, and how do response rates compare?

Alternatives like EGFR inhibitors or cetuximab with radiation or chemotherapy exist; responses can be meaningful but are often not durable, especially in older, comorbid populations.

S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD

Q: How do you approach evaluating a co‑morbid patient before considering immunotherapy?

Involves a multidisciplinary team approach, considering transplant status, immunosuppressive regimens, and overall cancer urgency, with a plan to balance risks and benefits for both cancer control and organ function.

S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD

Q: What makes the comorbidity burden in these CSCC patients different from other advanced skin cancers?

The patient population is typically older with multiple comorbidities, including organ transplants and chronic immunosuppression, which complicates immunotherapy choices and requires careful coordination with transplant teams.

S18 Ep33: Current Approaches and Future Directions for Early-Stage TNBC

Q: How should toxicity considerations influence ADC selection in the post-neoadjuvant/adjuvant setting?

Toxicity profiles, including hematologic toxicity and immunotherapy-related adverse events, guide how aggressive a regimen can be, with special attention to long-term toxicities in younger patients and the balance between efficacy and tolerability.

S18 Ep33: Current Approaches and Future Directions for Early-Stage TNBC

Q: What are the key eligibility criteria for these post-neoadjuvant ADC trials?

Most trials require residual disease in the breast or lymph nodes, with germline BRCA testing often used to screen out certain mutation carriers; the goal is to enroll patients with high relapse risk after neoadjuvant therapy.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

A biomedical-focused interview series features in-depth conversations with academic oncologists and physician-recholers who dissect cutting-edge oncology data, trials, and therapeutic strategies. Topics span targeted therapies, antibody-drug conjugates, immunotherapy combinations, precision oncology, and novel delivery methods across solid tumors and hematologic malignancies. Episodes emphasize practical takeaways for clinical practice, real-world constraints, biomarker-driven decision-making, and the evolving treatment landscape presented at major conferences. A standout pattern is how guests translate complex trial results into actionable insights for clinicians, with recurring attention to safety signals, sequencing, patient quality of l... more

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. JAMA Clinical Reviews
5. Research To Practice | Oncology Videos

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Michael K. Wong
2. Eric Whitman, MD
3. Sagar Lonial
4. Jennifer B. Valerin
5. Adam M. Brufsky
6. Jonathan Trent
7. Dr. Stephen Liu
8. Douglas W. Sborov

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days